Pfizer (PFE): Undervalued Pharma Giant Amid #Economy Resilience?Pfizer (PFE): Undervalued Pharma Giant Amid #Economy Resilience? $28.90 in Sight? 📈
At $24.04 (+0.04%), PFE offers a compelling entry with its low P/E of 12.72 and robust 7.15% dividend yield, trading well below analyst targets of $28.90 (20% upside potential)—could resilient economic forecasts boo
Key facts today
Pfizer's board declared a Q4 2025 cash dividend of $0.43 per share, payable December 1, 2025, to shareholders on record as of November 7, 2025.
Pfizer is in talks with the Trump administration about the TrumpRx initiative, allowing consumers to buy brand-name drugs directly at negotiated prices, launching next year.
490 ARS
7.34 T ARS
58.26 T ARS
About Pfizer, Inc.
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
ISIN
ARDEUT111424
FIGI
BBG000HG6JJ7
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Related stocks
Pfizer medium term outlook.This giant might not make you rich, but its in my opinion a safe bet for 2025>2026.
I have personally opened a long position due to my analysis.
Check my old bitcoin predictions from 4 years ago and you will see my eye is strong for longer term moves.
Make your own analysis and decision, this is
Pfizer and Pharma Stocks Rise After Trump DecisionPfizer Inc. (PFE) and Other Pharmaceutical Stocks Rise Following Trump’s Decision
According to media reports, US President Donald Trump launched a website allowing Americans to purchase medicines directly. He announced that Pfizer would offer some of its drugs on this platform and introduce new me
PFE: Bears Trapped at Multi-Year Lows - Spring Ready to Uncoil📍 **To see my confluences and/or linework:**
Step 1: Grab chart 📊
Step 2: Unhide Group 1 in object tree 🎯
Step 3: Hide and unhide specific confluences one by one ✨
Step 4: Double-click the screen to show RSI, MFI, CVD, and OBV indicators alongside divergence markings 📈
Title: 💊 PFE: Bears Trapp
Pfizer: Long-Term Downtrend Still in Effect?Pfizer has spent almost two years consolidating after a major slide. Now some traders may see the long-term downtrend reasserting itself.
The first pattern on today’s chart is the pair of highs in July and August just above $26, which could be viewed as a double-top reversal pattern.
Second, the d
Back test before continuationNYSE:PFE after breaking out on trump deal and now working with him to sell their products through TrumpRx launching next year. They are also exempt from tariffs for 3 years and plan to invest 60B in the US. good support/resistance flip could take place here would like to hold 25 but 24 is possible.
Pfizer: Bearish Setup Points to Further Downside Risk Current Price: $23.76
Direction: SHORT
Targets:
- T1 = $22.50
- T2 = $21.50
Stop Levels:
- S1 = $24.50
- S2 = $25.30
**Wisdom of Professional Traders:**
This analysis synthesizes insights from thousands of professional traders and market experts who have been following Pfizer’s
Pfizer’s Next Big Shot: COVID Levels Back on the Table?Huge Crisis or Groundbreaking Discovery?
This scenario suggests that once the running flat correction is completed — which we are very close to — the price is set to explode by at least 300% in the coming years (see red box).
Why do I think so?
• The running correction is approaching its final ta
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063Yield to maturity
5.66%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
5.52%
Maturity date
May 19, 2053
P
PFE5588591
Pfizer Investment Enterprises Pte. Ltd. 5.11% 19-MAY-2043Yield to maturity
5.37%
Maturity date
May 19, 2043
See all PFE bonds
00963
CTBC Global High Dividend ETF Securities Investment Trust FundWeight
1.78%
Market value
615.71 K
USD
Explore more ETFs
Curated watchlists where PFE is featured.